CHAMPOUX JENNIFER (Chief Operating Officer) sold 3.4% of their position (2.17K shares) of MONTE ROSA THERAPEUTICS, INC. on the open market
Open‑market sale worth $43.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/28/2026ACC: 0001193125-26-245728
Officer· Chief Operating Officer
Since May 2024
-2.17K
Net shares
Net seller
$43.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.17K acquired · 4.35K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.17K
Price / share
$3.98
Trade value
$8.66K
% of position
3.5%
5/27/2026
62.37K→64.55K
Common Stock
Direct
Shares
−2.17K
Price / share
$20.00
Trade value
$43.50K
% of position
3.4%
5/27/2026
64.55K→62.37K
Total
Net shares
+0.00
Net value
-$34.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/27/2026 | M · Option Exercise | +2.17K | $3.98 | $8.66K | 3.5% | 62.37K | 64.55K |
| Common Stock Direct | 5/27/2026 | S · Sale | −2.17K | $20.00 | $43.50K | 3.4% | 64.55K | 62.37K |
| Total | +0.00 | -$34.84K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
2.17K shares
Shares
−2.17K
Strike price
3.98
Held after
35.65K
Exercisable
—
5/27/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock2.17K shares | 5/27/2026 | M · Option Exercise | −2.17K | 3.98 | — | 35.65K |